Real-time enrollment status for this merkel cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:07 AM UTC
| NCT Number | NCT05100095 |
| Recruiting Status | Recruiting |
| Condition | Merkel Cell Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 52 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | July 16, 2026 (Yesterday) |
As of July 17, 2026: Clinical trial NCT05100095 is currently recruiting participants. This phase2 study for merkel cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05100095 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05100095 was last updated Yesterday (July 16, 2026). HelloStudys verifies this status automatically.